NGFR and diabetic kidney disease: The therapeutic effects of the TrkA inhibitor GW441756 were evaluated in both DKD model mice and HG-stimulated podocytes.<h4>Results</h4>RNA sequencing detected NGFR upregulation in db/db mice.